Cannabinoid Hyperemesis Syndrome Caused Severe Vomiting Mistaken for Morning Sickness

Two pregnant women had repeated hospitalizations for severe vomiting that was ultimately traced to cannabinoid hyperemesis syndrome, with symptoms resolving after cannabis cessation.

Hanley, Sarah et al.·Obstetric medicine·2025·Preliminary EvidenceCase Report
RTHC-06631Case ReportPreliminary Evidence2025RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Case Report
Evidence
Preliminary Evidence
Sample
Not reported

What This Study Found

Two cases of CHS in pregnancy were described. Case 1: a woman with vomiting episodes at weeks 5, 14, and 30 of gestation; the link to hot bathing for relief led to CHS diagnosis. Symptoms resolved with cannabis cessation; healthy baby born at 38+5 weeks. Case 2: vomiting at weeks 16 and 18; 14+ year cannabis use history disclosed after hot bathing pattern identified. Symptoms resolved with cessation; baby born at 37 weeks with low birth weight (2180g) requiring 5 days in NICU. No relapse at 5 months postpartum with sustained cessation.

Key Numbers

Only 11 prior CHS-in-pregnancy cases reported in literature; Case 1: symptoms at weeks 5, 14, 30, resolved with cessation, healthy delivery at 38+5 weeks; Case 2: 14+ years cannabis use, low birth weight baby (2180g), 5 days NICU

How They Did This

Case series of two pregnant women diagnosed with cannabinoid hyperemesis syndrome, with clinical workup, treatment course, and outcomes documented through delivery and postpartum follow-up.

Why This Research Matters

CHS in pregnancy is likely underdiagnosed because severe nausea and vomiting are expected symptoms of pregnancy. When anti-emetic treatments fail, the hot bathing clue should prompt inquiry about cannabis use. Misdiagnosis leads to repeated hospitalizations and delays appropriate management.

The Bigger Picture

As cannabis use during pregnancy increases (6-10% by recent estimates), CHS cases in pregnancy will likely rise. The condition is easily missed when clinicians attribute all vomiting to typical pregnancy-related nausea.

What This Study Doesn't Tell Us

Case series of only two patients. Cannot establish prevalence. Case 2 had confounding factors (14+ years of heavy cannabis use, low birth weight may have multiple causes). No standardized CHS diagnostic criteria applied.

Questions This Raises

  • ?How many cases of pregnancy hyperemesis are actually undiagnosed CHS?
  • ?Should routine prenatal intake include specific CHS screening questions?

Trust & Context

Key Stat:
Evidence Grade:
Preliminary: case series of two patients, contributing to a very small literature on this topic.
Study Age:
2025 publication
Original Title:
Cannabinoid hyperemesis syndrome in pregnancy: a case series and review.
Published In:
Obstetric medicine, 18(4), 264-271 (2025)
Database ID:
RTHC-06631

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / Observational
Case Report / Animal StudyOne case or non-human subjects
This study

Describes what happened to one person or a small group.

What do these levels mean? →

Read More on RethinkTHC

Cite This Study

RTHC-06631·https://rethinkthc.com/research/RTHC-06631

APA

Hanley, Sarah; Imcha, Mendinaro; Mohamad, Mas Mahady. (2025). Cannabinoid hyperemesis syndrome in pregnancy: a case series and review.. Obstetric medicine, 18(4), 264-271. https://doi.org/10.1177/1753495X241307415

MLA

Hanley, Sarah, et al. "Cannabinoid hyperemesis syndrome in pregnancy: a case series and review.." Obstetric medicine, 2025. https://doi.org/10.1177/1753495X241307415

RethinkTHC

RethinkTHC Research Database. "Cannabinoid hyperemesis syndrome in pregnancy: a case series..." RTHC-06631. Retrieved from https://rethinkthc.com/research/hanley-2025-cannabinoid-hyperemesis-syndrome-in

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.